Clinical Trial Update: Puerarin Versus Atorvastatin in Treating Metabolism Syndrome in Patients With Chronic Rheumatic Diseases [NA]

View source ↗

Summary

An update on a study comparing puerarin versus atorvastatin for metabolic syndrome in rheumatoid arthritis patients; the current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Puerarin (puerarin)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Chengdu PLA General Hospital | Conditions: Rheumatoid Arthritis | NA | Status: UNKNOWN